 <h1>Nedocromil Side Effects</h1><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Professional</li>
<li>Interactions</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p><i>Applies to nedocromil: inhalation aerosol with adapter</i></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects have included unpleasant taste which was reported in approximately 13% of patients receiving nedocromil and resulted in drug withdrawal in up to 3%.  Less commonly, nedocromil has caused nausea and vomiting (2% to 4%).<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Throat irritation may be relieved by drinking water before and after inhalation of nedocromil.  Use of a beta-2 agonist prior to nedocromil inhalation may relieve cough and bronchospasm.<sup>[Ref]</sup></p><p>Respiratory side effects have included cough and throat irritation in 6% to 7% of patients treated with nedocromil.  Bronchospasm has been induced in 5% of patients.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Nervous system side effects have included headache in up to 6% of patients treated.  Less commonly dizziness has been reported.<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Hepatic side effects have included elevations of liver function tests (SGPT) in approximately 3% of patients treated with nedocromil.<sup>[Ref]</sup></p><p id="ref_1">1. Dejong JW, Teengs JP, Postma DS, Vandermark TW, Koeter GH, Demonchy JGR "Nedocromil sodium versus albuterol in the management of allergic asthma." Am J Respir Crit Care Med 149 (1994): 91-7</p><p id="ref_2">2. Rebuck AS, Kesten S, Boulet LP, Cartier A, Cockcroft D, Gruber J, Laberge F, Lee-Chuy E, Keshmiri M, MacDonald GF, et al "A 3-month evaluation of the efficacy of nedocromil sodium in asthma: a randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group." J Allergy Clin Immunol 85 (1990): 612-7</p><p id="ref_3">3. Gonzalez JP, Brogden RN "Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease." Drugs 34 (1987): 560-77</p><p id="ref_4">4. Foulds RA "An overview of human safety data with nedocromil sodium." J Allergy Clin Immunol 92 (1993): 202-4</p><p id="ref_5">5. Brogden RN, Sorkin EM "Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma." Drugs 45 (1993): 693-715</p><p id="ref_6">6. "Product Information. Tilade (nedocromil)." Rhone-Poulenc Rorer, Collegeville, PA. </p><p id="ref_7">7. Parish RC, Miller LJ "Nedocromil sodium." Ann Pharmacother 27 (1993): 599-606</p><h2>More about nedocromil</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: mast cell stabilizers</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Asthma, Maintenance</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>